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ABSTRACT

Background: Certain risk factors for cognitive decline appear modifiable. A potentially modifiable marker of
inflammation, C-reactive protein may be associated with cognitive deficits, although not all studies have found
a relationship between C-reactive protein and cognitive ability. Further, few research papers have examined
whether gender may affect any association between C-reactive protein and cognitive deficit.
Methods: To better understand the association between C-reactive protein, cognitive deficit, and gender in
elderly people, we meta-analyzed cross-sectional studies that reported cognitive ability assessed by the MiniMental State Examination or an equivalent measure, C-reactive protein concentrations, and gender.
Results: While we identified no studies containing only male subjects, the two identified studies containing
both female and male subjects (n = 2,525) showed an effect size for cognition of −0.1809 (95% confidence
interval, −0.2652 to −0.0967, p = 0.000025) between high and low C-reactive-protein groups. In contrast,
the two identified studies containing only female subjects (n = 1,754) showed an effect size for cognition of
0.0345 (95% confidence interval, −0.0594 to 0.1285, not significant).
Conclusions: In the context of a small number of source studies and lack of an all-male group, these results
suggest that any association between C-reactive protein and cognitive deficits may be stronger in elderly men
than in elderly women.
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Introduction
Cognitive decline and dementia are important
public health problems, but some risk factors
for cognitive decline and dementia are potentially
modifiable (Kukull, 2006). Adults tend to peak
in cognitive ability at age 40 and then show a
gradual decline in cognitive functioning thereafter
(Anderson et al., 2001). This decline involves a
wide range of cognitive domains including executive
functioning, processing speed, memory, and
attention (Clark et al., 2006). Years of education,
genetics, general health, and socioeconomic status
can affect cognitive decline (Compton et al., 2003),
as well as a variety of medical and neurological
conditions. Furthermore, inflammation may be a
factor in cognitive decline (Dziedzic, 2006).
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C-reactive protein (CRP) is a biomarker for
general inflammation, and high levels of CRP
are associated with cardiovascular disease, stroke,
cancer, and obesity (Ho and Lipman, 2009). In
addition, elevated levels of CRP may be associated
with cognitive deficits. Based on their review of
six studies investigating the association between
CRP and cognitive function, Kuo et al. (2005)
concluded that elevated CRP is associated with
cognitive decline and the progression of Alzheimer’s
disease. In a study of subjects with schizophrenia,
Dickerson et al. (2007) found that while CRP was
not associated with psychosis, patients with CRP
levels higher than 5.0 mg/μL had significantly lower
cognitive functioning than those with CRP levels
less than 5.0 mg/μL. In a prospective study of
cognitive function in older adults (n = 650), Tilvis
et al. (2004) reported that cognitive decline at 5
years was associated with elevated CRP. Similarly,
Yaffe et al. (2003) determined that levels of
interleukin-6 and CRP are associated with cognitive
deficits but only in subjects having the highest levels
of these proteins.
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In contrast to studies showing an association
between CRP and cognitive deficits, Aiello
et al. (2006) investigated whether CRP modified
the association between cytomegalovirus, herpes
simplex virus type-1, and cognitive function and
found that although there was a relationship
between high levels of cytomegalovirus and
cognitive deficit, the latter was not modified by
CRP. Dik et al. (2005) retrospectively examined
cognitive functioning in a large cohort (n = 1284)
in relation to four inflammatory proteins and
concluded that cognitive decline was associated
with high levels of α 1 - antichymotrypsin but not
CRP, interleukin-6, and albumin. Other research
suggests that high inflammatory protein levels only
have an effect on cognition in the presence of
moderating variables. Alley et al. (2008) assessed
levels of interleukin-6 and CRP in relation to
baseline cognitive functioning and cognitive change
over time. Initial results indicated that high levels of
these inflammatory proteins were associated with
lower baseline cognition. However, these effects
were not present after control for confounding.
Finally, Teunissen et al. (2003) reported that while
CRP appears to have an effect on some aspects of
cognitive performance, there was no overall strong
relationship between CRP and cognitive decline.
Among the studies that found a relationship
between CRP and cognition, gender differences
were unexplored. Gender, however, could be
an important factor in the relationship between
CRP and cognition in that previous research has
consistently shown that there are gender differences
in cognitive functioning among older individuals
(Finkel et al., 2006). Examining gender differences
in cognition in 2,307 older adults, Aartsen et al.
(2004) found that women had better memory
function than men. In a group of 578 older adults,
women performed better on verbal memory tasks
than did men (van Hooren et al., 2007). The
apparent cognitive differences between elderly men
and women indicate that gender may affect any
association between CRP and cognition in the
elderly.
To better understand the association between
CRP and cognition in older women and men, we
meta-analyzed cross-sectional studies comparing
cognition assessed by the Mini-Mental State
Examination (MMSE; Folstein et al., 1975) or an
MMSE-based assessment and reporting CRP levels
and gender.

Methods
Paper selection
Using the electronic databases PubMed and
PsychInfo, we identified peer-reviewed studies that
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examined the relationship between CRP and cognitive functioning with the following search terms:
“C-reactive protein AND cognition”, Interleukin-6
AND cognition, inflammatory proteins AND cognition, cognition disorders AND C-reactive protein,
and cognitive impairment AND C-reactive protein.
Searches were repeated with neuropsychological
function replacing cognition and inflammation
replacing inflammatory. After identifying relevant
papers, we reviewed the reference sections of these
papers to identify additional relevant papers.
Inclusion criteria
Identified papers were included in the study if they
were written in English, contained MMSE scores or
scores from an MMSE-based assessment, and their
means and standard deviations or standard errors
in high and low CRP groups (i.e. high tertile versus
low tertile, high quintile versus low quintile, etc.),
and the gender composition of the samples.
We included only studies that assessed cognitive
function using the MMSE or an MMSEbased measure to minimize heterogeneity between
cognitive assessments in the source studies. Because
cognitive tests can differ in sensitivity and specificity,
outcomes from different cognitive tests assessing
similar constructs can produce different results.
For example, assessing memory functioning in a
sample of mild brain-injury patients, Guilmette
and Rasile (1995) found that the use of cognitive
tests of varying sensitivity and specificity led to
a diagnostic accuracy ranging from 68% to 83%.
Accordingly, we included only studies that used the
MMSE (Folstein et al., 1975) or an MMSE-based
assessment of cognitive functioning because of its
widespread use in clinical practice and research
(Nieuwenhuis-Mark, 2010).
Statistical analysis
We calculated standardized effect sizes for each
identified study by subtracting the mean MMSE
score for the low CRP group from the mean MMSE
score for the high CRP group and dividing the
difference by the pooled estimate of the standard
deviation of the cognitive scores. To correct for
bias from small sample sizes, we obtained an
unbiased estimator of effect size by multiplying the
standardized effect size by the J-correction factor
to obtain the Hedges g statistic (Hedges and Olkin,
1985; Borenstein et al., 2009). We then combined
the individual effect sizes and associated variance
according to the methods given by Whitehead
(2002). We also calculated a U statistic (distributed
as a χ 2 ) to test for the significance of the combined
effect sizes from the individual studies and a Q
statistic (also distributed as a χ 2 ), which evaluates
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Table 1. Characteristics of the source studies
n

S T U DY

AGE

D I C H O T O M I Z AT I O N

COGNITIVE MEASURE

..................................................................................................................................................................................................................................................................

Komulainen et al., 2007
Tilvis et al., 2004
Weuve et al., 2006
Yaffe et al., 2003

64
629
1690a
1896

63.77
79.65
71.79
73.63

high to low tertile
high half to low half
high to low quintile
high to low tertile

MMSE
MMSE
Phone Interviewb
Revised MMSE

MMSE = Mini Mental State Examination.
a approximate number.
b The correlation coefficient between the Phone Interview and the MMSE is 0.94.

Table 2. Scores on cognitive measure for high and low CRP groups
S T U DY

HIGH CRP

L OW C R P

HIGH CRP GROUP

N

N

MEAN

L OW C R P G R O U P

(SD)

MEAN

(SD)

...........................................................................................................................................................................................................................................................................

Komulainen et al., 2007
Tilvis et al., 2004
Weuve et al., 2006
Yaffe et al., 2003

18
549
844
966

46
80
846
930

28.7 (1.7)
22.6 (5.4)
34.2 (2.6)
88.7 (9.3)

28.2 (2.0)
23.7 (7.0)
34.1 (3.0)
90.4 (9.1)

Notes: CRP = C-reactive protein; SD = standard deviation.

Table 3. Combined male and female subjects
n

m

SD

SEM

ES

VA R

(ES)

................................................................................................................................................................................................................................................................

Tilvis et al., 2004
Yaffe et al., 2003

high CRP
low CRP
high CRP
low CRP

80
549
966
930

22.6
23.7
88.7
90.4

5.37
7.03
9.32
9.15

χ2

df

p

1
1
−0.1809
−0.2652

0.000025
ns

U
17.7285
Q
0.0331
pooled effect size
confidence interval

0.60
0.30
0.30
0.30

−0.1606

0.0143

−0.1839

0.0021

to −0.0967

Note: CRP = C-Reactive Protein; SD = standard deviation; SEM = standard error of the mean; ES = effect size;
var (ES) = variance of the effect size; ns = not significant.

consistency among the individual effect sizes. A
significant Q value warns of heterogeneity among
the source studies (Borenstein et al., 2009).

Results
After screening abstracts and titles for potential
studies, we retrieved and reviewed 46 full papers.
From these, we identified four papers that met the
inclusion criteria (Table 1). We excluded papers
if they failed to measure cognitive status with the
MMSE or an MMSE-based assessment, if they
did not report cognitive function in high and
low groups of CRP, if the sample was primarily
composed of people with medical or neurological
diseases that might affect cognitive functioning,
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or if the participants were selected because of a
cognitive disorder. In addition, we excluded papers
that did not include the data needed to calculate
effect sizes, such as mean MMSE scores and their
standard deviations or standard errors or that used
longitudinal rather than cross-sectional designs.
Cognitive scores for the high and low CRP groups
in each study are shown in Table 2.
Two of the identified studies used both male
and female subjects (Yaffe et al., 2003; Tilvis et al.,
2004), whereas the other two papers included only
female subjects (Weuve et al., 2006; Komulainen
et al., 2007). The combined analysis of the
four identified studies produced a U value of
7.04 (p = 0.008); however, the Q statistic (11.26)
was significant (p = 0.010), indicating significant
heterogeneity among the four source studies and
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Table 4. Female subjects only
n

M

SD

SEM

ES

VA R

(ES)

................................................................................................................................................................................................................................................................................................................

Komulainen et al., 2007
Weuve et al., 2006

high CRP
low CRP
high CRP
low CRP

U
Q
pooled effect size
confidence interval

18
46
844
846

28.7
28.7
34.2
34.1

1.70
2.00
2.60
3.00

χ2

df

p

0.5196
0.0159

1
1

ns
ns

0.40
0.29
0.09
0.10

0.0000

0.0773

0.0356

0.0024

0.0345
−0.0594 to 0.1285

Note: CRP = C-Reactive Protein; SD = standard deviation; SEM = standard error of the mean; ES = effect size; var (ES) = variance
of the effect size; ns = not significant.

suggesting that combing them into a summary
statistic was inappropriate. The U statistic for the
male–female combined group (with a total number
of subjects of 2,525) was significant (U = 17.73,
p = 0.000025) with a pooled effect size of −0.1809
(95% confidence interval, −0.2652 to −0.0967,
p = 0.000025, Table 3), indicating that the cognitive
performance of the low CRP subjects was higher
than the cognitive performance of the high CRP
subjects. Further, the Q statistic (0.033) was not
significant, indicating that it was appropriate to
combine the individual effects sizes into a summary
measure. In contrast, the U statistic for the allfemale studies (with a total of 1,754 subjects,
although 96.4% of the subjects came from just
one of the two studies) was not significant (U =
0.520) with a pooled effect size of 0.0345 (95%
confidence interval, −0.0594 to 0.1285, Table 4).
The Q statistic (0.016) also was not significant,
indicating that it was appropriate to combine effects.
The difference in effect size between the two groups
(combined male–female groups versus the allfemale group) suggests that CRP may be associated
with lower cognitive scores in the combined group
than in the female-only group).

Discussion
The primary aim of this study was to determine
whether gender affects the association between
CRP concentrations and cognitive ability in elderly
people. Indeed, even though there was a significant
difference in cognitive ability between high and low
CRP groups overall (p = 0.008), the associated Q
statistic indicated significant heterogeneity between
studies. When female-only source studies and male–
female combined source studies were analyzed
separately, the associated Q statistics became nonsignificant, indicating that it was appropriate to pool
those particular source studies into one effect size.
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Upon doing this, the effect size between the high
and low CRP groups in the female-only sample
was not significant, but the difference between high
and low CRP groups in the combined male–female
sample was significant (p = 0.000025). As such, the
main finding is that CRP is significantly associated
with deficits in general cognitive ability determined
by the MMSE or MMSE-related methods in
samples composed of both women and men but not
in the women-only samples. This finding suggests
that the association between CRP and cognitive
deficits may be stronger in men than in women.
That is, cognitive ability in elderly men may be more
susceptible to elevated concentrations of CRP than
in elderly women. If so, findings on the association
between CRP and cognition may tend toward
inconsistency unless gender is taken into account.
Broadly consistent with the observation that
cognition in elderly men may be more susceptible
to elevated levels of CRP than it is in elderly women
are findings that men aged 70–89 years have a
higher prevalence of mild cognitive impairment than
do women (Petersen et al., 2010). Further, older
men appear to have more cognitive deficits than do
older women (Aartsen et al., 2004; Finkel et al.,
2006; van Hooren et al., 2007). Men may generally
be more susceptible to the deleterious effects of
inflammation than are women as suggested by
the finding that CRP was associated with a 12%
reduction in survival time and a one-year reduction
in expected lifespan in men but not in women
(Wassel et al., 2010). While factors in addition to
inflammation may well contribute to differences in
cognitive ability between elderly men and women,
part of the difference in cognitive deficits between
older women and men could be due to differential
susceptibility to CRP.
The cross-sectional design of this metaanalysis precludes an assessment of the causal
relationship between CRP and cognitive deficits
wherein cognitive deficits could lead to elevated
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CRP concentrations instead of elevated CRP
concentrations resulting in cognitive deficits.
Similarly, we did not investigate other potentially
confounding variables such as smoking history and
socioeconomic status that may alter the association
between CRP concentrations and cognitive deficits.
Several additional factors temper the interpretation of the findings reported herein. Only four
studies met our inclusion criteria. Two of these
reported data on only female subjects, two reported
data on combined female–male sample, and none
reported data on male-only subjects. We therefore
based the analysis on the percentage of male or
female subjects and not solely on male samples
versus female samples. If anything though, this
design would tend to underestimate the differences
between women and men. If there is a difference
between women and men, an all-male sample
compared to an all-female sample would show
a greater difference between groups than would
the available mixed male–female sample we used
compared to an all-female sample. Although the
number of source studies in the meta-analysis was
small, the results are based on a fairly large number
of individual subjects. An additional limitation,
however, is that in the female-only studies, one
study contributed 96.4% of the subjects; in the
mixed-sex samples, one study contributed 75.1%
of the subjects.
In summary, the association between CRP and
cognitive deficits appeared stronger in elderly men
than in elderly women in this small meta-analysis,
although limitations based primarily on the small
numbers of source studies and factors common
to all cross-sectional designs limit this conclusion
and make the results susceptible to new studies.
Within the context of these limitations, the results
suggest that gender may be an important variable
to consider when studying the association between
inflammation and cognition.
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